BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
DTSTART:20260308T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20261101T010000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260804T041726Z
UID:F16854A1-D57F-4ECF-B6D2-64ED0374F2A3
DTSTART;TZID=America/New_York:20260925T100000
DTEND;TZID=America/New_York:20260925T110000
DESCRIPTION:Abstract:\n\nSodium channel\, are linked to monogenic causes of
  variable onset epilepsy\, autism spectrum disorder\, and epileptic enceph
 alopathies. While the mechanism for SCN2A haploinsufficiency and concomita
 nt loss of function has been explored in detail\, the impact of missense S
 CN2A variants is less clear due to a paucity of studies looking at neurona
 l function. To address this roadblock\, we applied high-throughput all-opt
 ical electrophysiology to patient-derived neurons with the p.M1879T varian
 t compared to CRIPSR-corrected isogenic lines. We complemented the finding
 s in these ‘Optopatch’ experiments with conventional patch-clamp elect
 rophysiology. The p.M1879T variant neurons had significantly increased fir
 ing rates compared to isogenic controls at higher and longer optical stimu
 li\, indicating increased firing reserve. These neurons tended to fire lat
 er into the pulse as well\, demonstrating resistance to depolarization blo
 ck. Machine learning-based classification was able to differentiate the ne
 uron genotype with high accuracy (&gt;95%) based on these evoked firing param
 eters. We further applied high-throughput optical electrophysiology to cha
 racterize the effect of different clinically available sodium channel bloc
 king agents on evoked neuronal firing: carbamazepine\, phenytoin\, lacosam
 ide\, and cenobamate. Compared to DMSO-treated controls\, all anti-seizure
  medications resulted in a dose-dependent reduction of evoked firing. Sele
 ct concentrations of drugs were able to partially rescue the variant firin
 g close to isogenic levels\, demonstrating translational application of ou
 r in vitro findings. These results provide the first application of high-t
 hroughput iPSC-derived neuron electrophysiology and pharmacology in SCN2A-
 related disorders\, demonstrating proof that this platform can be readily 
 applied to a variety of monogenic models of epilepsy\n\nSpeaker(s): Sashmi
 ta\, \n\nAgenda: \n10.00 am - Introduction of the speaker\n\n10.05 am - Pr
 esentation\n\n10.45 am - Q&amp;A session\n\n11.00 am - Conclusion\n\nVirtual: 
 https://events.vtools.ieee.org/m/570819
LOCATION:Virtual: https://events.vtools.ieee.org/m/570819
ORGANIZER:mguduri@ltu.edu
SEQUENCE:18
SUMMARY:xcitatory Neuron Dysfunction and Pharmacologic Rescue in an SCN2A G
 ain-of-Function Variant Associated with Early-Onset Epilepsy using Machine
  Learning approach
URL;VALUE=URI:https://events.vtools.ieee.org/m/570819
X-ALT-DESC:Description: &lt;br /&gt;&lt;p&gt;Abstract:&lt;/p&gt;\n&lt;p&gt;Sodium channel\, are lin
 ked to monogenic causes of variable onset epilepsy\, autism spectrum disor
 der\, and epileptic encephalopathies. While the mechanism for SCN2A haploi
 nsufficiency and concomitant loss of function has been explored in detail\
 , the impact of missense SCN2A variants is less clear due to a paucity of 
 studies looking at neuronal function. To address this roadblock\, we appli
 ed high-throughput all-optical electrophysiology to patient-derived neuron
 s with the p.M1879T variant compared to CRIPSR-corrected isogenic lines. W
 e complemented the findings in these &amp;lsquo\;Optopatch&amp;rsquo\; experiments
  with conventional patch-clamp electrophysiology. The p.M1879T variant neu
 rons had significantly increased firing rates compared to isogenic control
 s at higher and longer optical stimuli\, indicating increased firing reser
 ve. These neurons tended to fire later into the pulse as well\, demonstrat
 ing resistance to depolarization block. Machine learning-based classificat
 ion was able to differentiate the neuron genotype with high accuracy (&amp;gt\
 ;95%) based on these evoked firing parameters. We further applied high-thr
 oughput optical electrophysiology to characterize the effect of different 
 clinically available sodium channel blocking agents on evoked neuronal fir
 ing: carbamazepine\, phenytoin\, lacosamide\, and cenobamate. Compared to 
 DMSO-treated controls\, all anti-seizure medications resulted in a dose-de
 pendent reduction of evoked firing. Select concentrations of drugs were ab
 le to partially rescue the variant firing close to isogenic levels\, demon
 strating translational application of our in vitro findings. These results
  provide the first application of high-throughput iPSC-derived neuron elec
 trophysiology and pharmacology in SCN2A-related disorders\, demonstrating 
 proof that this platform can be readily applied to a variety of monogenic 
 models of epilepsy&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;Agenda: &lt;br /&gt;&lt;p&gt;10.00 am - Introduction
  of the speaker&lt;/p&gt;\n&lt;p&gt;10.05 am - Presentation&lt;/p&gt;\n&lt;p&gt;10.45 am - Q&amp;amp\;
 A session&lt;/p&gt;\n&lt;p&gt;11.00 am - Conclusion&lt;/p&gt;
END:VEVENT
END:VCALENDAR

